Skip to main content
Year archive

CYCLOPHARM LIMITED — 2020 filings

All 40 regulatory filings released by CYCLOPHARM LIMITED (CYC) in 2020, sourced directly from the official regulator.

40 Filings
2020 Period
2020 filings (40)
Filing Released Lang
Bell Potter Healthcare Conference 25 pages 6.9MB
Investor Presentation
2020-11-25 English
Change of Director's Interest Notice TM 2 pages 162.1KB
Director's Dealing
2020-10-21 English
Change of Director's Interest Notice 2 pages 215.0KB
Director's Dealing
2020-09-30 English
Change of Director's Interest Notice 2 pages 215.0KB
Director's Dealing
2020-09-28 English
Cyclopharm Investor Presentation 49 pages 9.1MB
Investor Presentation
2020-09-22 English
Technegas USA Trial Successfully Meets Primary Endpoint 3 pages 202.1KB
Regulatory Filings
2020-09-14 English
CYC Partners With McMasters University In COVID-19 Research 2 pages 151.2KB
Regulatory Filings
2020-09-08 English
Dividend/Distribution - CYC 4 pages 24.9KB
Notice of Dividend Amount
2020-08-24 English
Half Yearly Report and Accounts 41 pages 1.5MB
Interim / Quarterly Report
2020-08-24 English
Half Year 2020 Financial Results 4 pages 161.5KB
Interim / Quarterly Report
2020-08-24 English
Appendix 2A 34 pages 667.4KB
Capital/Financing Update
2020-07-26 English
Change of Director's Interest Notice 2 pages 140.3KB
Director's Dealing
2020-07-26 English
Chairman's Address to Shareholders 4 pages 153.7KB
AGM Information
2020-07-08 English
CYC 2020 AGM Presentation 29 pages 7.1MB
AGM Information
2020-07-08 English
Managing Director's Address to Shareholders 7 pages 254.3KB
Investor Presentation
2020-07-08 English
Results of Meeting 2 pages 143.6KB
Declaration of Voting Results & Voting Rights Announcements
2020-07-08 English
CYC 1H2020 Business Update 6 pages 215.2KB
Interim / Quarterly Report
2020-07-06 English
Notice of Annual General Meeting/Proxy Form 22 pages 1.5MB
AGM Information
2020-06-04 English
Technegas Approved in Russia - Clarification 1 page
Regulatory Filings
2020-05-28 English
USFDA Approval to File Received for Technegas 2 pages 149.0KB
Capital/Financing Update
2020-05-26 English
Technegas Approved in Russia 2 pages 118.1KB
Capital/Financing Update
2020-05-25 English
Final share buy-back notice - Appendix 3F 2 pages 150.2KB
Transaction in Own Shares
2020-05-20 English
Form 484 cancellation of Long Term Incentive Plan shares 2 pages 9.9KB
Share Issue/Capital Change
2020-05-05 English
Appendix 2A 34 pages 723.7KB
Regulatory Filings
2020-05-04 English
USFDA Grants Cyclopharm USD$2.9m Application Fee Waiver 2 pages 193.9KB
Capital/Financing Update
2020-04-13 English
Annual Report to shareholders 98 pages 2.2MB
Annual Report
2020-03-30 English
CYC Appendix 4G 23 pages 436.3KB
Governance Information
2020-03-30 English
Cyclopharm Lodges NDA for Technegas with the USFDA 2 pages 165.2KB
Capital/Financing Update
2020-03-29 English
Cyclopharm Company Update 2 pages 231.3KB
Regulatory Filings
2020-03-23 English
Change of Director's Interest Notice 2 pages 205.4KB
Director's Dealing
2020-03-16 English
Change of Director's Interest Notice 2 pages 215.2KB
Director's Dealing
2020-03-16 English
Change of Director's Interest Notice 2 pages 205.1KB
Director's Dealing
2020-03-12 English
Cyclopharm Investor Presentation 46 pages 3.0MB
Investor Presentation
2020-03-02 English
Change of Director's Interest Notice 2 pages 205.1KB
Director's Dealing
2020-03-01 English
Dividend/Distribution - CYC 4 pages 25.1KB
Notice of Dividend Amount
2020-02-25 English
Preliminary Final Report 68 pages 540.6KB
Annual Report
2020-02-25 English
Change in substantial holding 2 pages 667.6KB
Regulatory Filings
2020-01-14 English
Change in substantial holding 2 pages 669.5KB
Regulatory Filings
2020-01-14 English
Change in substantial holding 2 pages 579.5KB
Regulatory Filings
2020-01-12 English
Becoming a substantial holder 4 pages 111.4KB
Regulatory Filings
2020-01-02 English